MetaADEDB 2.0 @ LMMD
Opalmon
(AURWGUVCKQSRJX-UYCJUBBXSA-N)
Structure
SMILES
OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]3[C@@H](CO)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@H]1[C@@H]([C@H]2O)O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@@H]([C@H]3O)O)CO.CCCC[C@@H](C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCC/C=C\C(=O)O)O)C
Molecular Formula:
C57H94O35
Molecular Weight:
1339.340
Log P:
-9.5577
Hydrogen Bond Acceptor:
35
Hydrogen Bond Donor:
21
TPSA:
569.73
CAS Number(s):
88852-12-4
Synonym(s)
1.
Opalmon
External Link(s)
PubChem Compound6436038
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute bronchitisOFFSIDES
2Altered state of consciousnessOFFSIDES
3AngioplastyOFFSIDES
4AnosmiaOFFSIDES
5Arteriosclerosis ObliteransOFFSIDES
6AscitesOFFSIDES
7Aspiration PneumoniaOFFSIDES
8AsthmaOFFSIDES
9Atrioventricular BlockOFFSIDES
10Bacteria urine identifiedOFFSIDES
11Blood alkaline phosphatase increasedOFFSIDES
12Blood amylase increasedOFFSIDES
13Blood beta-D-glucan increasedOFFSIDES
14Blood creatine phosphokinase decreasedOFFSIDES
15Blood immunoglobulin A decreasedOFFSIDES
16Blood immunoglobulin EOFFSIDES
17Blood immunoglobulin G decreasedOFFSIDES
18Blood immunoglobulin M decreasedOFFSIDES
19Blood lactate dehydrogenase increasedOFFSIDES
20Blood phosphorus increasedOFFSIDES
21Blood sodiumOFFSIDES
22BradycardiaOFFSIDES
23Cauda Equina SyndromeOFFSIDES
24Cerebral ThrombosisOFFSIDES
25Cervical myelopathyOFFSIDES
26Clostridium colitisOFFSIDES
27Concomitant disease aggravatedOFFSIDES
28Disseminated Intravascular CoagulationOFFSIDES
29EczemaOFFSIDES
30Embolic strokeOFFSIDES
31EpiglottitisOFFSIDES
32Erosive gastritisOFFSIDES
33ErythemaOFFSIDES
34Focal glomerulosclerosisOFFSIDES
35Gamma-Glutamyltransferase IncreasedOFFSIDES
36Gastric ulcerOFFSIDES
37Gastrointestinal perforationOFFSIDES
38Helicobacter pylori identification test positiveOFFSIDES
39Implant site effusionOFFSIDES
40InfectionOFFSIDES
41Large intestine perforationOFFSIDES
42LeukoencephalopathyOFFSIDES
43Lung InjuryOFFSIDES
44Lymphocyte count decreasedOFFSIDES
45Lymphocyte stimulation testOFFSIDES
46Micturition frequency decreasedOFFSIDES
47Mucosal erosionOFFSIDES
48Muscle WeaknessOFFSIDES
49Muscular DystrophyOFFSIDES
50OsteomyelitisOFFSIDES
51Oxygen ConsumptionOFFSIDES
52PO2 decreasedOFFSIDES
53PemphigusOFFSIDES
54PericarditisOFFSIDES
55PeritonitisOFFSIDES
56Psoas AbscessOFFSIDES
57Pulmonary HypertensionOFFSIDES
58RalesOFFSIDES
59Renal Artery StenosisOFFSIDES
60Respiratory FailureOFFSIDES
61RhabdomyolysisOFFSIDES
62SclerodermaOFFSIDES
63Small Intestinal StenosisOFFSIDES
64SpondylolisthesisOFFSIDES
65StridorOFFSIDES
66Surgical vascular shuntOFFSIDES
67Toe operationOFFSIDES
68Tolosa-Hunt SyndromeOFFSIDES
69Upper respiratory tract inflammationOFFSIDES
70Urine output increasedOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.